Clinical trial

Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer

NCT01832870

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-04-01

PhasePHASE1

Study timeline

Study start (unknown)2013-04-01Date precision: month

Registry last updated2017-08-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Castrate Resistant Prostate Cancerunresolved

Interventions

sipuleucel-TDRUG · verified · RxNorm: sipuleucel-T

ipilimumabDRUG · verified · RxNorm: ipilimumab

Sponsors & collaborators

Prostate Oncology Specialists, Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01832870 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.